Original Research
Accepted on 29 Oct 2025
Synergistic anti-tumor activity of the mTOR inhibitor everolimus and gemcitabine for relapsed/refractory peripheral T cell lymphoma
in T Cell Biology
Original Research
Accepted on 29 Oct 2025
in T Cell Biology
Systematic Review
Accepted on 29 Oct 2025
in Thyroid Endocrinology
Data Report
Accepted on 29 Oct 2025
in Veterinary Infectious Diseases
Original Research
Accepted on 29 Oct 2025
in Thoracic Oncology
Original Research
Accepted on 29 Oct 2025
in Orthopedic Surgery
Original Research
Accepted on 29 Oct 2025
in Smart Technologies and Cities
General Commentary
Accepted on 29 Oct 2025
in Cryospheric Sciences
Mini Review
Accepted on 29 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 29 Oct 2025
in Veterinary Pharmacology and Toxicology
Systematic Review
Accepted on 29 Oct 2025
in Planted Forests
Original Research
Accepted on 29 Oct 2025
in Geoscience and Society
Original Research
Accepted on 29 Oct 2025
in Visceral Surgery
Original Research
Accepted on 29 Oct 2025
in Behavioral and Psychiatric Genetics
Review
Accepted on 29 Oct 2025
in Cancer Molecular Targets and Therapeutics
Editorial
Accepted on 29 Oct 2025
in Neuro-Otology
Brief Research Report
Accepted on 29 Oct 2025
in Conservation and Restoration Ecology